Tel: +1 617 973 2713
Greg Madden joined SVLS in 2002 and has deep private and public financing and M&A experience. Greg is also a proven investor relations and portfolio strategy executive who spearheads the firm's fundraising and LP relations efforts. Greg is currently a board observer on portfolio investments AcuFocus, CardioFocus and Allocure. Prior deal assignments include: Achillion Pharmaceuticals (ACHN), Auxilium Pharmaceuticals (AUXL), CHF Solutions (acquired), Concentric Medical (acquired), Ikano Therapeutics (acquired), Insulet (PODD), LenSx Lasers (acquired), NeurogesX (NGSX), and Orchid Pharmaceuticals (ORCD). Prior to joining SVLS, Greg worked at Testa, Hurwitz & Thibeault, in the Business Practice, Emerging Technology and Private Equity groups, supporting both venture capital funds and venture backed companies in business formations and financings, mergers and acquisitions, and venture capital fundraising. Greg received his BA with honors from Colby College and received his MBA with High Honors from Boston University graduating Beta Gamma Sigma.